Eculizumab for congenital atypical hemolytic-uremic syndrome

N Engl J Med. 2009 Jan 29;360(5):544-6. doi: 10.1056/NEJMc0809959.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Complement C5 / antagonists & inhibitors*
  • Hemolytic-Uremic Syndrome / congenital*
  • Hemolytic-Uremic Syndrome / drug therapy
  • Humans
  • Immunologic Factors / therapeutic use*
  • Infant
  • Male
  • Recurrence

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Complement C5
  • Immunologic Factors
  • eculizumab